The High Court ruled on a significant patent dispute involving Pfizer and GSK, addressing costs and confidentiality.

GSK said it will use its established manufacturing network in Belgium to support production. The companies will also work together to research, develop and manufacture several mRNA vaccine ...

GSK has made another investment in its manufacturing ... unveiled plans to build a $270 million-plus vaccines facility in Belgium.

GSK Plc is in talks to buy biotech company IDRx, people with knowledge of the matter said, a deal that would see the British drugmaker further boost its growing oncology portfolio. The purchase ...

As a leading developer of vaccines, GSK has a part to play in this, with experts who are well positioned to provide insights into the vaccines of today, and those that are to come. Disease burden ...

(Bloomberg) -- When Elliott Investment Management came calling for the ouster of Emma Walmsley, the chief executive officer ...